OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Endocrinology Diabetes and Obesity is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	37
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts	34
Updates in thyroid healthcare delivery: advancing patient-centered care	32
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	31
The female athlete triad: review of current literature	30
Nutrition and thyroid disease	28
Advances in assessment and treatment of bone, mineral and parathyroid disorders	27
Advances in the care of lipodystrophies	26
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	26
Editorial introduction	25
Editorial introductions	24
Editorial introduction	24
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	23
Financial toxicity in thyroid cancer survivors	20
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	20
An update on bone in diabetes	20
Recent advances in anaplastic thyroid cancer management	20
Preventing type 1 diabetes development and preserving beta-cell function	19
Update on fracture risk assessment in osteoporosis	17
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	17
Editorial introduction	16
The use of anabolic agents in the treatment of osteoporosis: a clinical update	15
Interactions between antidiabetes medications and heart–brain axis	15
Gastrointestinal hormones and regulation of gastric emptying	15
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	14

Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	13
Epidemiologic changes in thyroid disease	13
Long-acting amylin analogues for the management of obesity	12
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	12
Fibrous dysplasia in children and its management	12
Assisted reproductive technology outcomes and management considerations for people with epilepsy	11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Growth and development in type 1 diabetes	11
Lipidomics in diabetes	11
Precision medicine in diabetes care	11
The uncommon forms of congenital adrenal hyperplasia	11
Type 2 diabetes: a contemporary view from the Asian lens	10
Editorial introductions	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
A short history of saturated fat: the making and unmaking of a scientific consensus	10
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	10
Editorial introductions	9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
An update on investigation and management of renal bone disease	9
Adrenal insufficiency and pregnancy	9
Legislation, medicine, and politics: care for gender diverse youth	9
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	9
Novel techniques for assessment of bone tissue material properties	9
An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture	8
Indications for testosterone therapy in men	8
Editorial introductions	8
The interaction between gut microbiome and bone health	8
Early anthropometric indicators of type 2 diabetes mellitus	8
Time to cycle regularity and health risks	8
Multifactorial chylomicronemia syndrome	8
Continuous glucose monitoring in primary care – are we there?	7
Type 2 diabetes mellitus and cognitive function: understanding the connections	7
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	7
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease	7
Advanced imaging and theranostics in thyroid cancer	7